Bone Biologics Corp - warrants — Quarterly Balance Sheet (NASDAQ:BBLGW)

Financials

Total revenue 00000 0 Gross profit 00000 0 Operating expenses 951.02 K1.55 M1.04 M748.08 K715.28 K 4.06 M Selling/general/admin expenses 521.27 K450.37 K614.91 K556.47 K527.47 K 2.15 M Research & development 429.75 K1.1 M423.58 K191.61 K187.81 K 1.91 M Operating income -951.02 K-1.55 M-1.04 M-748.08 K-715.27 K -4.06 M Non-Operating Income, Total 10.02 K33.22 K21.39 K7 55648.54 K 110.71 K Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 10.02 K33.22 K21.39 K7 55648.54 K 110.71 K Unusual income/expense ————— — Pretax income -941 K-1.52 M-1.02 M-740.52 K-666.74 K -3.95 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -941 K6.69 M1 M-740.52 K-666.74 K 6.28 M Discontinued operations ————— — Net income -941 K6.69 M1 M-740.52 K-666.74 K 6.28 M Dilution adjustment 0———0 — Preferred dividends 3.21 M———0 — Diluted net income available to common stockholders -4.15 M6.69 M1 M-740.52 K-666.74 K 6.28 M Basic earnings per share (Basic EPS) -17.22-2.89-1.92-1.310.74 -5.38 Diluted earnings per share (Diluted EPS) -17.22-2.89-1.92-1.310.74 -5.38 Average basic shares outstanding 199.38 K252.87 K530.53 K544.28 K965.8 K 2.29 M Diluted shares outstanding 199.38 K252.87 K530.53 K544.28 K965.8 K 2.29 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —